After a court issued a ruling last spring that a Yemeni detainee held in U.S. custody should be released, the opinion was briefly published in the case docket and then abruptly withdrawn for classification review. When it reappeared, reporter Dafna Linzer discovered, it was not only redacted but had been significantly altered.
“The alterations are extensive,” she found. “Sentences were rewritten. Footnotes that described disputes and discrepancies in the government’s case were deleted. Even the date and circumstances of [the detainee’s] arrest were changed.”
Yet in what seems like an insult to the integrity of the judicial process, no indication was given that the original opinion had been modified — not just censored — as a consequence of the classification review. ProPublica obtained both versions of the ruling and published a comparison of them, highlighting the missing or altered passages. See “In Gitmo Opinion, Two Versions of Reality” by Dafna Linzer, ProPublica (co-published with The National Law Journal), October 8.
We sat down with biomedical research pioneer Lee Hood to talk moonshots, metascience in medicine, and the Human Phenome Initiative.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”